🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety and efficacy of pembrol...
Status
Completed
Location
St Joseph Heritage Healthcare-Oncology ( Site 0004)
Start Date
2021-10-07
Trial ID
NCT05008224
The safety and efficacy of pembrolizumab plus the investigator's choice of ...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham-Medicine ( Site 0065)
Start Date
2021-06-18
Trial ID
NCT04895358
Treatments Being Tested
The purpose of this research study is to see how useful it is to look at bi...
Status
Unknown
Location
Princess Margaret Cancer Centre
Start Date
2023-02-23
Trial ID
NCT05065021
Treatments Being Tested
This is a Phase 2 clinical trial with a 2:1 randomization comparing neoadju...
Status
Recruiting
Location
University of California, Irvine
Start Date
2025-08-21
Trial ID
NCT06624475
Treatments Being Tested
The primary objective is to determine if mutation load underlies sensitivit...
Status
Terminated
Location
Columbia University
Start Date
2016-05-31
Trial ID
NCT02710396
Treatments Being Tested
This clinical trial will evaluate a new combination of pembrolizumab, HPV-1...
Status
Completed
Location
UPMC Hillman Cancer Center
Start Date
2020-07-06
Trial ID
NCT04369937
Treatments Being Tested
The goal of this study is to learn if people who receive intismeran autogen...
Status
Recruiting
Location
Banner MD Anderson Cancer Center ( Site 0181)
Start Date
2024-10-21
Trial ID
NCT06623422
Treatments Being Tested
Primary Objectives: 1. To determine the maximum tolerated dose (MTD) or ma...
Status
Terminated
Location
UC San Diego Moores Cancer Center
Start Date
2017-03-27
Trial ID
NCT03059147
The main goals are after treatment given before surgery, to measure the num...
Status
Recruiting
Location
Southern Cancer Center (SCC) ( Site 8004)
Start Date
2025-03-20
Trial ID
NCT06788912
This phase II, multicenter, single-arm, open-label study evaluates first-li...
Status
Not Yet Recruiting
Location
West China Hospital, Chengdu, Sichuan 610000
Start Date
2026-08
Trial ID
NCT07715565
Treatments Being Tested